By Chelsea A. Jack and Mark B. Herzog
Two studies published this month—one about schizophrenia and the other about autism spectrum disorder—describe genetic and clinical ... Read more »
By Rachel Sachs
Wendy Chung’s commentary last month about the FDA’s proposed draft guidance for the regulation of laboratory-developed tests (LDTs) is heavily critical of ... Read more »
by Wendy Chung, MD, PhD
Associate Professor of Pediatrics (in Medicine)
Columbia University Medical Center
The American laboratory industry and its ability to serve patients is being ... Read more »
By Maya Sabatello
Genetic testing to identify the susceptibility of individuals to developing specific disorders or to confirm diagnoses is becoming increasingly common in clinical ... Read more »
By Nancy Berlinger, PhD
Recently, I spoke with a seasoned health care reporter who was interested in Alzheimer’s and biomarkers because of his own family’s ... Read more »
Knowledge About Dementia Predisposition Reduces Cognitive Performance
December 23, 2013
By: Paul S. Appelbaum, M.D.
Ethicists and others have been concerned that the disclosure of ... Read more »
January 9, 2014
By: Josephine Johnston
The introduction in 2011 of new, highly accurate, non-invasive prenatal genetic tests garnered a significant amount of media attention. ... Read more »
December 20, 2013
By: Josephine Johnston
On November 22nd, the FDA sent a Warning Letter to 23andMe ordering it to immediately discontinue marketing and ... Read more »
Challenging Monolithic Conceptions of Complex Disorders: Schizophrenia and Autism Spectrum Disorder